BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

826 related articles for article (PubMed ID: 30357434)

  • 1. Exploring the effect of microdosing psychedelics on creativity in an open-label natural setting.
    Prochazkova L; Lippelt DP; Colzato LS; Kuchar M; Sjoerds Z; Hommel B
    Psychopharmacology (Berl); 2018 Dec; 235(12):3401-3413. PubMed ID: 30357434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-blinding citizen science to explore psychedelic microdosing.
    Szigeti B; Kartner L; Blemings A; Rosas F; Feilding A; Nutt DJ; Carhart-Harris RL; Erritzoe D
    Elife; 2021 Mar; 10():. PubMed ID: 33648632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microdosing psychedelics: personality, mental health, and creativity differences in microdosers.
    Anderson T; Petranker R; Rosenbaum D; Weissman CR; Dinh-Williams LA; Hui K; Hapke E; Farb NAS
    Psychopharmacology (Berl); 2019 Feb; 236(2):731-740. PubMed ID: 30604183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microdosing psychedelics: Motivations, subjective effects and harm reduction.
    Lea T; Amada N; Jungaberle H; Schecke H; Klein M
    Int J Drug Policy; 2020 Jan; 75():102600. PubMed ID: 31778967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking.
    Kuypers KP; Riba J; de la Fuente Revenga M; Barker S; Theunissen EL; Ramaekers JG
    Psychopharmacology (Berl); 2016 Sep; 233(18):3395-403. PubMed ID: 27435062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of modafinil on non-verbal cognition, task enjoyment and creative thinking in healthy volunteers.
    Müller U; Rowe JB; Rittman T; Lewis C; Robbins TW; Sahakian BJ
    Neuropharmacology; 2013 Jan; 64(5):490-5. PubMed ID: 22820554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LSD and creativity: Increased novelty and symbolic thinking, decreased utility and convergent thinking.
    Wießner I; Falchi M; Maia LO; Daldegan-Bueno D; Palhano-Fontes F; Mason NL; Ramaekers JG; Gross ME; Schooler JW; Feilding A; Ribeiro S; Araujo DB; Tófoli LF
    J Psychopharmacol; 2022 Mar; 36(3):348-359. PubMed ID: 35105186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Out of the box: A psychedelic model to study the creative mind.
    Kuypers KPC
    Med Hypotheses; 2018 Jun; 115():13-16. PubMed ID: 29685188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perceived outcomes of psychedelic microdosing as self-managed therapies for mental and substance use disorders.
    Lea T; Amada N; Jungaberle H; Schecke H; Scherbaum N; Klein M
    Psychopharmacology (Berl); 2020 May; 237(5):1521-1532. PubMed ID: 32043165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Associations of Naturalistic Classic Psychedelic Use, Mystical Experience, and Creative Problem Solving.
    Sweat NW; Bates LW; Hendricks PS
    J Psychoactive Drugs; 2016; 48(5):344-350. PubMed ID: 27719438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microdosing psychedelics: Subjective benefits and challenges, substance testing behavior, and the relevance of intention.
    Petranker R; Anderson T; Maier LJ; Barratt MJ; Ferris JA; Winstock AR
    J Psychopharmacol; 2022 Jan; 36(1):85-96. PubMed ID: 33591231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study.
    Cavanna F; Muller S; de la Fuente LA; Zamberlan F; Palmucci M; Janeckova L; Kuchar M; Pallavicini C; Tagliazucchi E
    Transl Psychiatry; 2022 Aug; 12(1):307. PubMed ID: 35918311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motives and Side-Effects of Microdosing With Psychedelics Among Users.
    Hutten NRPW; Mason NL; Dolder PC; Kuypers KPC
    Int J Neuropsychopharmacol; 2019 Jul; 22(7):426-434. PubMed ID: 31152167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Dose of Creativity: An Integrative Review of the Effects of Serotonergic Psychedelics on Creativity.
    Costa MÂ
    J Psychoactive Drugs; 2023; 55(3):299-309. PubMed ID: 35895868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microdosing psychedelics: More questions than answers? An overview and suggestions for future research.
    Kuypers KP; Ng L; Erritzoe D; Knudsen GM; Nichols CD; Nichols DE; Pani L; Soula A; Nutt D
    J Psychopharmacol; 2019 Sep; 33(9):1039-1057. PubMed ID: 31303095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Viability of Microdosing Psychedelics as a Strategy to Enhance Cognition and Well-being - An Early Review.
    Bornemann J
    J Psychoactive Drugs; 2020; 52(4):300-308. PubMed ID: 32362269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of divergent and convergent thinking on visuomotor adaptation in young and older adults.
    Simon A; Bock O
    Hum Mov Sci; 2016 Apr; 46():23-9. PubMed ID: 26707677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcutaneous vagus nerve stimulation (tVNS) enhances divergent thinking.
    Colzato LS; Ritter SM; Steenbergen L
    Neuropsychologia; 2018 Mar; 111():72-76. PubMed ID: 29326067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Relationship Between Subthreshold Autistic Traits, Ambiguous Figure Perception and Divergent Thinking.
    Best C; Arora S; Porter F; Doherty M
    J Autism Dev Disord; 2015 Dec; 45(12):4064-73. PubMed ID: 26272675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic study of microdosing psychedelics.
    Polito V; Stevenson RJ
    PLoS One; 2019; 14(2):e0211023. PubMed ID: 30726251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.